Weissenburger J - Search Results

1

Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.

Cheymol G, Poirier JM, Carrupt PA, Testa B, Weissenburger J, Levron JC, Snoeck E. Cheymol G, et al. Among authors: weissenburger j. Br J Clin Pharmacol. 1997 Jun;43(6):563-70. doi: 10.1046/j.1365-2125.1997.00609.x. Br J Clin Pharmacol. 1997. PMID: 9205815 Free PMC article. Clinical Trial.

2

The pharmacokinetics of dexfenfluramine in obese and non-obese subjects.

Cheymol G, Weissenburger J, Poirier JM, Gellee C. Cheymol G, et al. Among authors: weissenburger j. Br J Clin Pharmacol. 1995 Jun;39(6):684-7. Br J Clin Pharmacol. 1995. PMID: 7654489 Free PMC article. Clinical Trial.

3

Comparison of the cardiac electrophysiological effects of flecainide and hydroquinidine in anesthetized dog: concentration-response relationship.

Chézalviel F, Weissenburger J, Ertzbischoff O, Poirier JM, Harlé X, Davy JM, Biour M, Cheymol G. Chézalviel F, et al. Among authors: weissenburger j. J Cardiovasc Pharmacol. 1990 Jan;15(1):50-6. doi: 10.1097/00005344-199001000-00008. J Cardiovasc Pharmacol. 1990. PMID: 1688982

4

Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.

Weissenburger J, Davy JM, Chézalviel F, Ertzbischoff O, Poirier JM, Engel F, Lainée P, Penin E, Motté G, Cheymol G. Weissenburger J, et al. J Pharmacol Exp Ther. 1991 Nov;259(2):871-83. J Pharmacol Exp Ther. 1991. PMID: 1941633

5

Comparative hemodynamic study of a new aminosteroid: LND-623 with its 20 alpha-isomer: LND-369, and with digoxin and digoxigenin-rhamnoside in the anesthetized dog.

Weissenburger J, Heckle J, Biour M, Poirier JM, Jarreau FX, Jaillon P, Cheymol G. Weissenburger J, et al. Fundam Clin Pharmacol. 1989;3(1):67-78. doi: 10.1111/j.1472-8206.1989.tb00032.x. Fundam Clin Pharmacol. 1989. PMID: 2653992

6

Proarrhythmic effects of a quinidine analog in dogs with chronic A-V block.

Chézalviel-Guilbert F, Weissenburger J, Davy JM, Guhennec C, Poirier JM, Cheymol G. Chézalviel-Guilbert F, et al. Among authors: weissenburger j. Fundam Clin Pharmacol. 1995;9(3):240-7. doi: 10.1111/j.1472-8206.1995.tb00291.x. Fundam Clin Pharmacol. 1995. PMID: 7557819

7

Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.

Chézalviel F, Weissenburger J, Guhennec C, Jagueux M, Davy JM, Vernhet L, Simandoux V, Poirier JM, Cheymol G. Chézalviel F, et al. Among authors: weissenburger j. J Cardiovasc Pharmacol. 1993 Feb;21(2):212-20. J Cardiovasc Pharmacol. 1993. PMID: 7679154

8

Plasma itraconazole concentrations in patients with neutropenia: advantages of a divided daily dosage regimen.

Poirier JM, Hardy S, Isnard F, Tilleul P, Weissenburger J, Cheymol G. Poirier JM, et al. Among authors: weissenburger j. Ther Drug Monit. 1997 Oct;19(5):525-9. doi: 10.1097/00007691-199710000-00007. Ther Drug Monit. 1997. PMID: 9357095 Clinical Trial.

9

[Sotalol-induced torsades de pointe in the conscious dog with atrioventricular block. Role of hypokalemia].

Davy JM, Weissenburger J, Ertzbischoff O, Lainée P, Chezalviel F, Poirier JM, Cheymol G, Motte G. Davy JM, et al. Among authors: weissenburger j. Arch Mal Coeur Vaiss. 1988 Sep;81(9):1117-24. Arch Mal Coeur Vaiss. 1988. PMID: 3143334 French.

10

Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.

Chézalviel-Guilbert F, Davy JM, Poirier JM, Weissenburger J. Chézalviel-Guilbert F, et al. Among authors: weissenburger j. J Am Coll Cardiol. 1995 Sep;26(3):787-92. doi: 10.1016/0735-1097(95)00234-U. J Am Coll Cardiol. 1995. PMID: 7642874 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page